Siyang Wang

机构：Shanxi Medical University, Second Hospital of Shanxi Medical University · ORCID：0000-0002-4009-0800

发表论文 96 篇 · 总被引 1923 次 · h-index 26

代表论文

• Single-cell dissection of cellular and molecular features underlying mesenchymal stem cell therapy in ischemic acute kidney injury (2023 · Molecular Therapy · 被引 34)
• The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis (2024 · Cancer Immunology Immunotherapy · 被引 19)
• Natural, tough and pH-responsive ultrasound modified soy protein isolate-arabinoxylan based double network hydrogels for controlled nutrients release (2025 · Food Hydrocolloids · 被引 18)
• Epigenetics in high-altitude adaptation and disease (2024 · 中国科学通报：英文版 · 被引 9)
• Abstract CT011: Penpulimab versus placebo in combination with chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A global, multicenter, randomized, double-blind, phase 3 trial (AK105-304) (2025 · Cancer Research · 被引 7)
• Phantom study and clinical application of total-body 18F-FDG PET/CT imaging: How to use small voxel imaging better? (2024 · EJNMMI Physics · 被引 7)